5 ms·

Are these all measesues for old people to live few more months? Or is it covid-19 shortening people life more in US than Sweden? 'The observed temporary excess

by slaw 6y ago

Are these all measesues for old people to live few more months? Or is it covid-19 shortening people life more in US than Sweden? 'The observed temporary excess mortality likely arises because people in vulnerable groups die weeks or months earlier than they would otherwise, due to the timing and severity of the unusual external event.' https://www.medrxiv.org/content/10.1101/2020.11.11.20229708v1.full https://www.medrxiv.org/content/10.1101/2020.11.11.20229708v...

xsmasher 6y ago
It's to allow people to live, on average, 11-13 more years. https://thehill.com/changing-america/well-being/longevity/497097-those-who-died-from-covid-19-lost-more-than-a-decade-of https://thehill.com/changing-america/well-being/longevity/49... It's also to keep heath services from being overwhelmed, which will cause a big spike in deaths from all causes.
- postalrat 6y ago
  I'd like to see how that average was calculated. I couldn't find in the paper how it was calculated. I assume it must be only counting people who died. Not sure how they count people who lived longer than expected? I'd also like to how it compares to other illnesses.
- slaw 6y ago
  11-13 more years is study for Italy from April 2020. It says also if people were not dying from other diseases. For comparison other diseases: "Using UK reports for approximate comparisons, the YLL for other conditions ranged, per capita from 8.2 for chronic obstructive pulmonary disease, 11.6 for coronary heart disease, 13.1 for pneumonia, and 21.6 for asthma"
fy20 6y ago
There's also the issue of "long covid" - people who before they caught it were perfectly healthy, but months later are still suffering from symptoms such as fatigue or breathlessness. I haven't seen any good data on how many people this affects, although it's estimated to be around 2% of those infected [0]. The important thing is these cases are often reported (by media) in young people, not just old people. What affect would it have on the economy if 2% of the working population suddenly couldn't work and needed life long welfare and medical support? [0] https://www.medrxiv.org/content/10.1101/2020.10.19.20214494v2 https://www.medrxiv.org/content/10.1101/2020.10.19.20214494v...

by slaw 6y ago

xsmasher 6y ago

It's to allow people to live, on average, 11-13 more years. https://thehill.com/changing-america/well-being/longevity/497097-those-who-died-from-covid-19-lost-more-than-a-decade-of https://thehill.com/changing-america/well-being/longevity/49... It's also to keep heath services from being overwhelmed, which will cause a big spike in deaths from all causes.

postalrat 6y ago
I'd like to see how that average was calculated. I couldn't find in the paper how it was calculated. I assume it must be only counting people who died. Not sure how they count people who lived longer than expected? I'd also like to how it compares to other illnesses.
slaw 6y ago
11-13 more years is study for Italy from April 2020. It says also if people were not dying from other diseases. For comparison other diseases: "Using UK reports for approximate comparisons, the YLL for other conditions ranged, per capita from 8.2 for chronic obstructive pulmonary disease, 11.6 for coronary heart disease, 13.1 for pneumonia, and 21.6 for asthma"

fy20 6y ago

There's also the issue of "long covid" - people who before they caught it were perfectly healthy, but months later are still suffering from symptoms such as fatigue or breathlessness. I haven't seen any good data on how many people this affects, although it's estimated to be around 2% of those infected [0]. The important thing is these cases are often reported (by media) in young people, not just old people. What affect would it have on the economy if 2% of the working population suddenly couldn't work and needed life long welfare and medical support? [0] https://www.medrxiv.org/content/10.1101/2020.10.19.20214494v2 https://www.medrxiv.org/content/10.1101/2020.10.19.20214494v...